Targeting CNTF to increase adult forebrain neurogenesis

靶向 CNTF 增加成人前脑神经发生

基本信息

  • 批准号:
    10406347
  • 负责人:
  • 金额:
    $ 42.87万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-09-01 至 2025-04-30
  • 项目状态:
    未结题

项目摘要

Project Summary. CNTF mediates the increased SVZ neurogenesis that occurs in the mouse brain after ischemic stroke. We will follow up on our finding that JNK in astrocytes represses CNTF expression and neurogenesis in naïve mice, to test whether systemic treatment with JNK inhibitor can increase neurogenesis after stroke. We will also block the highly related pro-inflammatory ligand IL-6, which we found reduces stroke- induced neurogenesis, with a gp130 inhibitor. Secondly, we have discovered that blood levels of vitronectin (VTN), produced by the liver, only increase in females after stroke, and leaks into the SVZ to induce IL-6 and repress the neurogenic response. We will identify the mechanisms that regulate VTN, focusing on vagal nerve stimulated muscarinic receptors and FAK. Thirdly, we discovered in males that castration caused an unexpected and very robust effect by increasing basal levels of pro-neurogenic CNTF and decreasing detrimental IL-6, and that this was retained after MCAO. We will define the differential signaling pathways underlying this male-specific mechanism and test whether pharmacological blocking of testosterone would increase neurogenesis in males. Aim 1 will determine whether a gp130 inhibitor promotes neurogenesis when given at 6 h or 2 months after a stroke in adult and aged mice, and whether it acts by blocking IL-6. We will also determine whether JNK inhibition would increase neurogenesis after stroke by increasing CNTF, and/or whether JNK inhibitor would further enhance the neurogenic effects of SC144 after MCAO. Aim 2 will define potentially female-specific mechanisms that regulate liver VTN, including FAK and muscarinic acetylcholine receptors, testing pharmacological FAK inhibition and the role of the nervous system innervation of the liver after MCAO. Aim 3 will define the signaling pathways that mediate testosterone’s effects on CNTF, LIF and IL- 6 expression in the SVZ after MCAO, and using intracerebral injection of testosterone after castration, with or without FAK, JNK, ERK or p38 inhibitors, and whether a testosterone blocker can promote neurogenesis after MCAO. These studies will build on our previous work to define novel fundamental intracellular signaling mechanisms that repress and enhance the key cytokines CNTF and IL-6 involved in SVZ neurogenesis following stroke.
项目摘要。睫状神经营养因子介导的增加SVZ神经发生发生在小鼠脑后, 缺血性中风我们将继续研究星形胶质细胞中JNK抑制CNTF表达, 在幼稚小鼠中的神经发生,以测试用JNK抑制剂的全身性治疗是否可以增加神经发生 中风后我们还将阻断高度相关的促炎配体IL-6,我们发现它可以减少中风- 用GP 130抑制剂诱导神经发生。其次,我们发现血液中的玻连蛋白水平 (VTN)由肝脏产生,仅在中风后女性中增加,并泄漏到SVZ中以诱导IL-6和IL-10。 抑制神经反应我们将确定调节VTN的机制,重点是迷走神经 刺激毒蕈碱受体和FAK。第三,我们发现,在男性,阉割造成了一个 通过增加前神经源性CNTF的基础水平和降低 白细胞介素-6(IL-6)是有害的,并且在MCAO后保留。我们将定义不同的信号通路 作为这种男性特异性机制的基础,并测试睾酮的药理学阻断是否会 增加雄性的神经发生。目的1将确定gp 130抑制剂是否促进神经发生, 在成年和老年小鼠中风后6小时或2个月给予,以及它是否通过阻断IL-6起作用。我们将 还确定JNK抑制是否会通过增加CNTF来增加中风后的神经发生,和/或 JNK抑制剂是否会进一步增强MCAO后SC 144的神经原性作用。目标2将定义 调节肝脏VTN的潜在女性特异性机制,包括FAK和毒蕈碱乙酰胆碱 受体,测试药理FAK抑制和神经系统的作用,对肝脏的神经支配 在MCAO之后。目的3将确定介导睾酮对CNTF、LIF和IL-1影响的信号通路。 6的表达,并采用去势后脑内注射睾酮, 没有FAK,JNK,ERK或p38抑制剂,以及睾酮阻滞剂是否可以促进神经发生后, MCAO。这些研究将建立在我们以前的工作,以确定新的基本细胞内信号 抑制和增强参与SVZ神经发生的关键细胞因子CNTF和IL-6的机制 中风后

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

THEO HAGG其他文献

THEO HAGG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('THEO HAGG', 18)}}的其他基金

Translational assessment of an FAK inhibitor for acute cerebroprotection
FAK 抑制剂急性脑保护作用的转化评估
  • 批准号:
    10673417
  • 财政年份:
    2023
  • 资助金额:
    $ 42.87万
  • 项目类别:
Targeting blood-derived integrin signaling after stroke
中风后靶向血液来源的整合素信号传导
  • 批准号:
    10392926
  • 财政年份:
    2018
  • 资助金额:
    $ 42.87万
  • 项目类别:
Targeting blood-derived integrin signaling after stroke
中风后靶向血液来源的整合素信号传导
  • 批准号:
    10155592
  • 财政年份:
    2018
  • 资助金额:
    $ 42.87万
  • 项目类别:
Targeting blood-derived integrin signaling after stroke
中风后靶向血液来源的整合素信号传导
  • 批准号:
    9923009
  • 财政年份:
    2018
  • 资助金额:
    $ 42.87万
  • 项目类别:
Targeting CNTF to increase adult forebrain neurogenesis
靶向 CNTF 增加成人前脑神经发生
  • 批准号:
    10619621
  • 财政年份:
    2007
  • 资助金额:
    $ 42.87万
  • 项目类别:
Targeting CNTF to increase adult forebrain neurogenesis
靶向 CNTF 增加成人前脑神经发生
  • 批准号:
    7891162
  • 财政年份:
    2007
  • 资助金额:
    $ 42.87万
  • 项目类别:
Targeting CNTF to increase adult forebrain neurogenesis
靶向 CNTF 增加成人前脑神经发生
  • 批准号:
    7483182
  • 财政年份:
    2007
  • 资助金额:
    $ 42.87万
  • 项目类别:
Targeting CNTF to increase adult forebrain neurogenesis
靶向 CNTF 增加成人前脑神经发生
  • 批准号:
    8099417
  • 财政年份:
    2007
  • 资助金额:
    $ 42.87万
  • 项目类别:
Targeting CNTF to increase adult forebrain neurogenesis
靶向 CNTF 增加成人前脑神经发生
  • 批准号:
    7315601
  • 财政年份:
    2007
  • 资助金额:
    $ 42.87万
  • 项目类别:
Targeting CNTF to increase adult forebrain neurogenesis
靶向 CNTF 增加成人前脑神经发生
  • 批准号:
    8722255
  • 财政年份:
    2007
  • 资助金额:
    $ 42.87万
  • 项目类别:

相似海外基金

Un/kindness, shame & resistance: the care of inpatients in NHS adult acute mental health units and how it might be improved
Un/善良,羞耻
  • 批准号:
    2885806
  • 财政年份:
    2023
  • 资助金额:
    $ 42.87万
  • 项目类别:
    Studentship
Post-Acute Care Transitions for Older Adult Medicare Beneficiaries with Serious Mental Illness
患有严重精神疾病的老年医疗保险受益人的急性后护理过渡
  • 批准号:
    10772386
  • 财政年份:
    2023
  • 资助金额:
    $ 42.87万
  • 项目类别:
Paving The Way to a Canadian Standard of Care with CAR-T Cellular Therapy: Phase II Trial of CD19 CAR-T for Relapsed/Refractory Adult Acute Lymphoblastic Leukemia (CLIC-01A)
通过 CAR-T 细胞疗法为加拿大护理标准铺平道路:CD19 CAR-T 治疗复发/难治性成人急性淋巴细胞白血病的 II 期试验 (CLIC-01A)
  • 批准号:
    474619
  • 财政年份:
    2022
  • 资助金额:
    $ 42.87万
  • 项目类别:
    Operating Grants
Investigating the impact acute inhalation of cannabis with a high content of delta-9-tetrahydrocannabinol has on myelination and microglia in adult and aged mice
研究急性吸入高含量 delta-9-四氢大麻酚的大麻对成年和老年小鼠髓鞘形成和小胶质细胞的影响
  • 批准号:
    485965
  • 财政年份:
    2022
  • 资助金额:
    $ 42.87万
  • 项目类别:
    Studentship Programs
Paving The Way to a Canadian Standard of Care with CAR-T Cellular Therapy: Phase II Trial of CD19 CAR-T for Relapsed/Refractory Adult Acute Lymphoblastic Leukemia (CLIC-01A)
通过 CAR-T 细胞疗法为加拿大护理标准铺平道路:CD19 CAR-T 治疗复发/难治性成人急性淋巴细胞白血病的 II 期试验 (CLIC-01A)
  • 批准号:
    466358
  • 财政年份:
    2022
  • 资助金额:
    $ 42.87万
  • 项目类别:
    Operating Grants
Metabolomics for prediction of cisplatin mediated acute kidney injury: a Canadian multi-centre adult and pediatric study
预测顺铂介导的急性肾损伤的代谢组学:加拿大多中心成人和儿童研究
  • 批准号:
    402040
  • 财政年份:
    2019
  • 资助金额:
    $ 42.87万
  • 项目类别:
    Operating Grants
Study of pathogenic mechanism of age-dependent chromosome translocation in adult acute lymphoblastic leukemia
成人急性淋巴细胞白血病年龄依赖性染色体易位发病机制研究
  • 批准号:
    18K16103
  • 财政年份:
    2018
  • 资助金额:
    $ 42.87万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Causal effect of time-varying driving pressures on mortality in mechanically ventilated, adult patients with acute respiratory distress syndrome
时变驱动压力对机械通气成年急性呼吸窘迫综合征患者死亡率的因果影响
  • 批准号:
    377313
  • 财政年份:
    2017
  • 资助金额:
    $ 42.87万
  • 项目类别:
    Studentship Programs
Role of SETBP1 in adult Ph+ acute lymphoblastic leukemia
SETBP1 在成人 Ph 急性淋巴细胞白血病中的作用
  • 批准号:
    9315111
  • 财政年份:
    2016
  • 资助金额:
    $ 42.87万
  • 项目类别:
Acute Inhibition of Adult-born Granule Cells and its Effect on Antidepressant Act
成体颗粒细胞的急性抑制及其抗抑郁作用
  • 批准号:
    8734273
  • 财政年份:
    2013
  • 资助金额:
    $ 42.87万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了